Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280494065> ?p ?o ?g. }
- W4280494065 abstract "Inhibitors of viral cell entry based on poly(styrene sulfonate) and its core-shell nanoformulations based on gold nanoparticles are investigated against a panel of viruses, including clinical isolates of SARS-CoV-2. Macromolecular inhibitors are shown to exhibit the highly sought-after broad-spectrum antiviral activity, which covers most analyzed enveloped viruses and all of the variants of concern for SARS-CoV-2 tested. The inhibitory activity is quantified in vitro in appropriate cell culture models and for respiratory viral pathogens (respiratory syncytial virus and SARS-CoV-2) in mice. Results of this study comprise a significant step along the translational path of macromolecular inhibitors of virus cell entry, specifically against enveloped respiratory viruses." @default.
- W4280494065 created "2022-05-22" @default.
- W4280494065 creator A5002550898 @default.
- W4280494065 creator A5006990270 @default.
- W4280494065 creator A5011055259 @default.
- W4280494065 creator A5013972886 @default.
- W4280494065 creator A5015543699 @default.
- W4280494065 creator A5017622442 @default.
- W4280494065 creator A5023643896 @default.
- W4280494065 creator A5025562595 @default.
- W4280494065 creator A5032280372 @default.
- W4280494065 creator A5034197691 @default.
- W4280494065 creator A5035991850 @default.
- W4280494065 creator A5037724522 @default.
- W4280494065 creator A5039969623 @default.
- W4280494065 creator A5047053079 @default.
- W4280494065 creator A5053069842 @default.
- W4280494065 creator A5061960494 @default.
- W4280494065 creator A5067068164 @default.
- W4280494065 creator A5072303851 @default.
- W4280494065 creator A5076451681 @default.
- W4280494065 creator A5079564403 @default.
- W4280494065 creator A5082627042 @default.
- W4280494065 creator A5082686586 @default.
- W4280494065 creator A5086352232 @default.
- W4280494065 creator A5089747417 @default.
- W4280494065 creator A5090925128 @default.
- W4280494065 date "2022-05-11" @default.
- W4280494065 modified "2023-10-15" @default.
- W4280494065 title "Macromolecular Viral Entry Inhibitors as Broad‐Spectrum First‐Line Antivirals with Activity against SARS‐CoV‐2" @default.
- W4280494065 cites W109065026 @default.
- W4280494065 cites W1892798832 @default.
- W4280494065 cites W1971868864 @default.
- W4280494065 cites W1987195459 @default.
- W4280494065 cites W1999364829 @default.
- W4280494065 cites W2025557523 @default.
- W4280494065 cites W2034588546 @default.
- W4280494065 cites W2047432734 @default.
- W4280494065 cites W2081781003 @default.
- W4280494065 cites W2083525619 @default.
- W4280494065 cites W2083890107 @default.
- W4280494065 cites W2092785485 @default.
- W4280494065 cites W2111773881 @default.
- W4280494065 cites W2129998516 @default.
- W4280494065 cites W2133396499 @default.
- W4280494065 cites W2134596993 @default.
- W4280494065 cites W2168527507 @default.
- W4280494065 cites W2169094920 @default.
- W4280494065 cites W2256756668 @default.
- W4280494065 cites W2342513272 @default.
- W4280494065 cites W2410066853 @default.
- W4280494065 cites W2760052061 @default.
- W4280494065 cites W2779102422 @default.
- W4280494065 cites W2803494954 @default.
- W4280494065 cites W2805774706 @default.
- W4280494065 cites W3014708904 @default.
- W4280494065 cites W3015960948 @default.
- W4280494065 cites W3026189060 @default.
- W4280494065 cites W3026265675 @default.
- W4280494065 cites W3028402548 @default.
- W4280494065 cites W3033019032 @default.
- W4280494065 cites W3033339088 @default.
- W4280494065 cites W3045637836 @default.
- W4280494065 cites W3045983745 @default.
- W4280494065 cites W3081172302 @default.
- W4280494065 cites W3081851173 @default.
- W4280494065 cites W3086643767 @default.
- W4280494065 cites W3096391348 @default.
- W4280494065 cites W3101498202 @default.
- W4280494065 cites W3107191813 @default.
- W4280494065 cites W3109824862 @default.
- W4280494065 cites W3110108367 @default.
- W4280494065 cites W3122883885 @default.
- W4280494065 cites W3126546961 @default.
- W4280494065 cites W3127811610 @default.
- W4280494065 cites W3128150988 @default.
- W4280494065 cites W3132930898 @default.
- W4280494065 cites W3138368670 @default.
- W4280494065 cites W3138734145 @default.
- W4280494065 cites W3159912178 @default.
- W4280494065 cites W3164191243 @default.
- W4280494065 cites W3173241791 @default.
- W4280494065 cites W3175183123 @default.
- W4280494065 cites W3188492164 @default.
- W4280494065 cites W3215020691 @default.
- W4280494065 cites W4200391585 @default.
- W4280494065 cites W4205562351 @default.
- W4280494065 cites W4207073452 @default.
- W4280494065 cites W4280494065 @default.
- W4280494065 doi "https://doi.org/10.1002/advs.202201378" @default.
- W4280494065 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35543527" @default.
- W4280494065 hasPublicationYear "2022" @default.
- W4280494065 type Work @default.
- W4280494065 citedByCount "4" @default.
- W4280494065 countsByYear W42804940652022 @default.
- W4280494065 countsByYear W42804940652023 @default.
- W4280494065 crossrefType "journal-article" @default.
- W4280494065 hasAuthorship W4280494065A5002550898 @default.
- W4280494065 hasAuthorship W4280494065A5006990270 @default.
- W4280494065 hasAuthorship W4280494065A5011055259 @default.